Abstract

cardiovascular diseases are considered significant causes of death in developed countries and increasingly in many developing countries. Among these, coronary heart disease (CHD) is the most common cardiovascular disease and is associated with high disability and mortality. Coronary artery disease is managed with medical therapy with or without myocardial revascularization. This article aims at examining issues of management of patients with coronary heart disease undergoing percutaneous coronary intervention (PCI) in particular with selective drug-eluting stent (DES).

Description